Current Hematologic Malignancy Reports
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 4.0 | Q2 | 74.8% | 1.191 | Q1 | 87.9% |
| 2024 | 3.3 | Q2 | 72.7% | 1.123 | Q1 | 87.0% |
| 2023 | 2.7 | Q3 | 46.0% | 0.998 | Q1 | 85.5% |
| 2022 | 2.9 | Q3 | 41.8% | 0.914 | Q2 | 84.1% |
| 2021 | 4.2 | Q3 | 57.1% | 1.125 | Q1 | 88.9% |
| 2020 | — | — | 1.299 | Q1 | 90.3% | |
| 2019 | — | — | 0.980 | Q2 | 85.2% | |
| 2018 | — | — | 1.149 | Q2 | 87.1% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1558-822X
ISSN
1558-8211
country
UScoverage
2006-2026